(Q50919180)

English

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.

scientific article published on 13 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial. (English)

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

0 references

phase III clinical trial

0 references

phase II clinical trial

0 references

14

object named as

Ray Borrow

1 reference

Europe PubMed Central

25 March 2018

Brian D. Plikaytis

13

object named as

Brian Plikaytis

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

George M Carlone

15

object named as

George Carlone

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

10

object named as

Helen Findlow

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

author name string

Siddhivinayak Hirve

1

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Ashish Bavdekar

2

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Anand Pandit

3

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Sanjay Juvekar

4

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Malini Patil

5

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Marie-Pierre Preziosi

6

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Yuxiao Tang

7

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Elisa Marchetti

8

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Lionel Martellet

9

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Cheryl Elie

11

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Varsha Parulekar

12

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Prasad S Kulkarni

16

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Akshay Goel

17

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Karupothula Suresh

18

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Suresh Beri

19

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Subhash Kapre

20

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Suresh Jadhav

21

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Jean-Marie Preaud

22

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Simonetta Viviani

23

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

F Marc LaForce

24

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

language of work or name

0 references

publication date

13 August 2012

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

30

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

45

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

6456-6460

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

The epidemiology of meningococcal disease in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

The Meningitis Vaccine Project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Meningococcal surrogates of protection--serum bactericidal antibody activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.004

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.08.004

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/22898557

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50919180&oldid=1888618496"